alisertib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadlactational amenorrhea

I am/have/hadabsolute neutrophil count

I am/have/hadmetastasis

I am/have/hadperiodic abstinence

I am/have/hadliver metastases

I am/have/hadlung cancer

I am/have/hadserum glucose

I am/have/hadsmall cell lung cancer

I am/have/hadpd-l1

I am/have/hadstage iva lung cancer ajcc v8

I am/have/hadtyrosine

I am/have/hadlung carcinoma recurrent

I am/have/hadnon-small cell lung cancer

I am/have/hadtumor cells

I am/have/hadstage ivb lung cancer ajcc v8

I am/have/hadliver metastasis

I am/have/hadstage iiib lung cancer ajcc v8

I am/have/hadstereotactic radiosurgery

added new label for I am/have/had

more

I am looking for

I am looking foralisertib

I am looking forgrowth factor

I am looking forglycosylated hemoglobin

I am looking forhba1c

I am looking forosimertinib

I am looking forblockade

I am looking fortyrosine

I am looking fortotal bilirubin

I am looking forsapanisertib

I am looking forhemoglobin a1c

I am looking forkinase inhibitor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Osimertinib With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

Osimertinib, alisertib, and sapanisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. The goal of part 1 of this trial is to find the highest tolerable dose of alisertib or sapanisertib in combination with osimertinib that can be given to patients …

liver metastases

non-small cell lung cancer

sapanisertib

tumor cells

stage ivb lung cancer ajcc v8

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.